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Early studies of pathogenesis and classification of 
human diseases in the late 19th and the first half 
of the 20th century were primarily based on mi-
croscopic examination of hematoxylin and eosin-
stained light microscopy slides and autopsy stud-
ies. The introduction of immunohistochemistry 
in the mid-70 enabled further identification and 
more precise classification of human diseases, par-
ticularly cancer diagnostics (1). In the past three 
decades, advances in molecular biology, genet-
ics, and genomics have dramatically changed the 
practice of diagnostic pathology worldwide (2). 
As never before, pathologists are at the crossroads 
between the traditionally ‘visible’ morphologic ap-
proach and an ‘invisible’ molecular science. 
Given that molecular diagnostics has become 
widely utilized in histopathologic diagnosis and 
clinical decision-making, the policymakers had 
to reframe the process of accreditation and re-ac-
creditation of the modern pathologists in context 
to the rapid changes taking place in this diagnos-
tic discipline. This has already been the case in 
most developed countries, while in the developing 
world, this integration has yet to be fully imple-
mented. In particular, the concept of “precision 
medicine” (including pathology) is rapidly evolv-
ing and becoming a cornerstone of modern can-
cer management (reviewed here by Vranic and 
Gatalica and nicely illustrated by a comprehensive 
case study of Trivedi et al.) (2, 3). Equally impor-
tant in the digital era are pathology informatics, as 
nicely reviewed in the paper of Kim et al. (4). Their 
experience with pathology informatics training 
and education during the challenging COVID-19 
pandemic at the Memorial Sloan Kettering Can-
cer Center is a good example of how informatics 
can be useful in solving current worldwide health 
problems (4).
This special issue of Acta Medica Academica 
highlights the advances in the understanding, di-
agnostics, and classification of various human can-
cers. You will note that the authors, all experts in 
their respective fields, approached their papers on 
various cancers in different ways. However, all the 
papers will clearly reflect the authors’ strong appre-
ciation for the progress made in the recent decades 
in diagnostic and molecular pathology. This prog-
ress has undoubtedly laid a firm foundation for the 
future of diagnostic and molecular pathology. 
In each of the following reviews (N=12), origi-
nal, case studies, and images in clinical medicine 
(N=4), the authors provide recent advances and 
perspectives that are only achieved by their active 
involvement in the forwarding paths of progress in 
diagnostic and molecular pathology. Each of the 
accepted manuscripts was selected based on their 
Editorial 
2
Acta Medica Academica 2021;50(1):1-3
professional and academic standing and contribu-
tions to diagnostic and molecular pathology. 
We are happy for contributions from different 
countries (United States, United Kingdom, Croa-
tia, Slovenia, Serbia, Qatar), including Bosnia and 
Herzegovina. All of the reviews contain in-depth 
and up to date information on testicular cancer 
(5), prostate cancer (6), endocervical adenocar-
cinoma (7), bladder cancer (8), pleural mesothe-
lioma (9), adult brain tumors (10), and Spitz mela-
nocytic lesions (11). In her review, Dr. Provenzano 
discussed the most recent advances and challenges 
in the assessment of breast cancer specimens fol-
lowing neoadjuvant chemotherapy (12). Two he-
matopathology reviews summarized the advances 
in this rapidly evolving branch of pathology (13, 
14); the first by Perry et al. summed up the criti-
cal aspects of diagnosis of the classical Hodgkin 
lymphoma (13), and the second one by Kurtović-
Kozarić et al. explored the recent advances and 
challenges in the diagnosis of myeloid neoplasms. 
It is worth noticing that the latter paper’s empha-
sis is on the improved hematopathology diagnos-
tics in Bosnia and Herzegovina, showing that the 
advances in pathology have no borders (14). The 
study of Gargano et al. confirmed the clinical util-
ity of ancillary molecular assays in cytologically 
indeterminate thyroid nodules (15), while Tomita 
comparatively analyzed the distribution of blood 
and lymphatic vessels in normal human vs. rhesus 
monkey samples (using immunohistochemistry 
on formalin-fixed and frozen section specimens) 
(16). Two studies (Trivedi et al.) (3) and Ibisevic 
et al. (17) illustrated the importance of the multi-
disciplinary approach and the role of (molecular) 
tumor boards in cancer management.
As the guest editors of this special issue of Acta 
Medica Academica, we would like to thank all the 
contributors for entrusting their work to this jour-
nal. These days, in the midst of the COVID-19 
epidemic, we are very proud that we managed to 
collate AMA’s special issue that contains scien-
tific contributions from many parts of the world. 
Like the former present of US Franklin Roosevelt 
in his last address to the nation, we would like to 
quote Thomas Jefferson from more than 200 years 
ago: “The brotherly spirit of science unites into 
one family all its votaries of whatever grade, and 
however, widely dispersed throughout the differ-
ent quarters of the globe.” To this quote, Roosevelt 
added “If civilization is to survive, we must culti-
vate the science of human relationships” (18) over-
coming national, ethnic, and political differences 
to forge a better world. 
At the end, we would like to express our deepest 
gratitude to all of the reviewers and the editorial 
staff of AMA, particularly to Mrs. Nerma Tanović. 
They have altruistically taken so much of their 
time to improve others’ work and served as guard-
ians of the medical literature. Our thanks also to 
Professor and Academician Husref Tahirović, who 
invited us to edit this special issue of AMA. We 
salute you all!
We hope that the readers of Acta Medica Aca-
demica will enjoy reading these articles as much as 
we have! 
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